Stage IV Ovarian Cancer Completed Phase 2 Trials for RG-4733 (DB11870)

IndicationStatusPhase
DBCOND0030167 (Stage IV Ovarian Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01175343RO4929097 in Treating Patients With Recurrent and/or Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerTreatment